2m 2m 2m 2m 2m 2m 2m
MEREO BIOPHA SP ADS (MREO)
NASDAQ
$0.34-$0.001 (-0.41%)
Price as of Jun 03, 2026 7:59 PM EDT- $54.9MMarket Cap
- -87.19%1-Year Change
- BiotechnologyIndustry
MEREO BIOPHA SP ADS (MREO)
$0.34-$0.001 (-0.41%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 500,000 N/A | 0 -100.00% | 10.0M -72.58% | 36.5M 0.00% | |
Cost of Revenue | 100,000 N/A | 0 -100.00% | 2.4M +356.41% | -936,000 -105.23% | |
Gross Profit | 400,000 N/A | 0 -100.00% | 7.6M -79.68% | 37.4M +101.55% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -17.8M -15.12% | -20.9M +20.16% | -17.4M -30.22% | -25.0M +5.96% | |
Depreciation and Amortization Expense | 465,000 +6.16% | 438,000 +10.89% | 395,000 -45.67% | 727,000 +13.24% | |
Total Operating Expenses | 23.0M -12.96% | 26.4M +43.48% | 18.4M N/A | N/A N/A | |
Operating Profit | -40.1M -15.32% | -47.4M +66.68% | -28.4M -34.78% | -43.6M +108.11% | |
Interest Income | 2.2M -28.54% | 3.0M +42.70% | 2.1M N/A | N/A N/A | |
Interest Expense | -255,000 -81.39% | -1.4M -52.45% | -2.9M N/A | N/A N/A | |
Interest Income and Expense and Net | 1.9M +14.78% | 1.7M +322.80% | -750,000 N/A | 0 N/A | |
Total Nonoperating Income and Expense | 300,000 N/A | 0 +100.00% | -10,000 N/A | N/A N/A | |
Income before Taxes | -41.9M -3.18% | -43.3M +44.19% | -30.0M N/A | N/A N/A | |
Income Taxes | 0 N/A | 0 +100.00% | -532,000 -71.96% | -1.9M -225.13% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -41.9M -3.18% | -43.3M +46.79% | -29.5M N/A | N/A N/A | |
Net Income from Continuing Operations Applicable to Common | -41.9M -3.18% | -43.3M +44.19% | -30.0M N/A | N/A N/A | |
Basic EPS and Net Income | -0.05 -16.67% | -0.06 +50.00% | -0.04 -33.33% | -0.06 -400.00% | |
Diluted EPS and Net Income | -0.05 -16.67% | -0.06 +50.00% | -0.04 -33.33% | -0.06 +20.00% | |
Basic Weighted Average Shares | 797.1M +7.77% | 739.6M +12.16% | 659.5M +9.33% | 603.2M +14.28% | |
Diluted Weighted Average Shares | 797.1M +7.77% | 739.6M +12.16% | 659.5M +9.33% | 603.2M +14.28% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 41.0M -41.27% | 69.8M +21.56% | 57.4M +1.93% | 56.3M -40.26% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 41.0M -41.27% | 69.8M +21.56% | 57.4M +1.93% | 56.3M -40.26% | |
Total Current Assets | 45.0M -39.78% | 74.8M +17.26% | 63.8M +2.62% | 62.1M -37.45% | |
Accumulated Depreciation | 1.1M +14.33% | 949,000 +18.63% | 800,000 N/A | N/A N/A | |
Property and Plant and Equipment and Net | 137,000 -46.69% | 257,000 -36.54% | 405,000 -77.88% | 1.8M -27.63% | |
Total Long-Term Assets | 137,000 -46.69% | 257,000 -36.54% | 405,000 -98.44% | 25.9M -4.23% | |
Total Assets | 45.9M -39.89% | 76.4M +14.87% | 66.5M -24.50% | 88.1M -30.33% | |
Income Taxes Payable | 2.4M -50.86% | 4.8M -21.01% | 6.1M N/A | N/A N/A | |
Total Short-Term Debt | 0 -100.00% | 5.5M N/A | 0 -100.00% | 11.1M N/A | |
Total Current Liabilities | 4.3M -68.93% | 13.8M +45.98% | 9.5M -61.56% | 24.7M +96.77% | |
Total Long-Term Debt | 3.8M N/A | 0 -100.00% | 4.4M N/A | N/A N/A | |
Total Long-Term Liabilities | 661,000 +16.99% | 565,000 -26.05% | 764,000 -50.16% | 1.5M -94.08% | |
Total Liabilities | 5.0M -67.57% | 15.4M -3.39% | 16.0M -39.10% | 26.2M -31.77% | |
Retained Earnings | -501.0M +8.24% | -462.9M +10.31% | -419.6M +26.71% | -331.2M +11.52% | |
Total Stockholders Equity | 40.9M -32.89% | 61.0M +20.64% | 50.5M -18.31% | 61.9M -29.70% | |
Total Shares Outstanding | 795.7M +2.57% | 775.7M +10.63% | 701.2M N/A | N/A N/A | |
Cash Flow | |||||
Cash from Operating Activities | -31.0M -5.67% | -32.8M +55.38% | -21.1M -45.56% | -38.8M +640.98% | |
Capital Expenditures | 20,000 N/A | N/A N/A | 0 N/A | N/A N/A | |
Cash from Investing Activities | -20,000 -97.14% | -699,000 +66.83% | -419,000 -127.99% | 1.5M +455.58% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 327,000 -99.29% | 46.1M +478.79% | 8.0M +1,116.96% | -784,000 -101.01% | |
Financials Ratio | |||||
Gross Margin | 80.00% N/A | N/A N/A | 76.00% -25.90% | 102.57% +101.55% | |
Operating Margin | -8,021.40% N/A | N/A N/A | -284.16% +137.82% | -119.48% +108.11% | |
Return on Assets | -68.48% +13.11% | -60.54% +58.80% | -38.12% N/A | N/A N/A | |
Return on Equity | -82.21% +5.96% | -77.58% +47.97% | -52.43% N/A | N/A N/A | |
Revenue Growth | N/A N/A | -100.00% +37.79% | -72.58% N/A | 0.00% N/A | |
Current Ratio | 10.46 +93.84% | 5.40 -19.68% | 6.72 +166.96% | 2.52 -68.21% | |
Cash Ratio | 9.53 +89.04% | 5.04 -16.73% | 6.05 +165.15% | 2.28 -69.64% | |
Debt-to-Equity Ratio | 0.09 +2.31% | 0.09 +4.49% | 0.09 N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.08 +14.21% | 0.07 +9.68% | 0.07 N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow